Goldman Sachs Group Inc. Purchases 175,866 Shares of Owens & Minor, Inc. $OMI

Goldman Sachs Group Inc. boosted its stake in shares of Owens & Minor, Inc. (NYSE:OMI) by 43.9% in the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 576,799 shares of the company’s stock after buying an additional 175,866 shares during the period. Goldman Sachs Group Inc. owned 0.75% of Owens & Minor worth $5,208,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds also recently bought and sold shares of OMI. Versant Capital Management Inc lifted its holdings in Owens & Minor by 537.6% during the first quarter. Versant Capital Management Inc now owns 3,201 shares of the company’s stock worth $29,000 after buying an additional 2,699 shares during the period. Parallel Advisors LLC lifted its holdings in Owens & Minor by 1,387.0% during the first quarter. Parallel Advisors LLC now owns 3,316 shares of the company’s stock worth $30,000 after buying an additional 3,093 shares during the period. Quarry LP purchased a new stake in Owens & Minor during the first quarter worth $34,000. Headlands Technologies LLC purchased a new stake in Owens & Minor during the first quarter worth $55,000. Finally, GAMMA Investing LLC lifted its holdings in Owens & Minor by 713.4% during the first quarter. GAMMA Investing LLC now owns 9,265 shares of the company’s stock worth $84,000 after buying an additional 8,126 shares during the period. Hedge funds and other institutional investors own 98.04% of the company’s stock.

Analyst Ratings Changes

OMI has been the subject of a number of analyst reports. Robert W. Baird lowered their target price on Owens & Minor from $10.00 to $7.00 and set an “outperform” rating for the company in a report on Tuesday, August 12th. UBS Group set a $7.00 price objective on Owens & Minor in a report on Wednesday, August 13th. Citigroup reiterated a “buy” rating and set a $7.00 price objective (down previously from $11.00) on shares of Owens & Minor in a report on Tuesday, August 12th. Zacks Research lowered Owens & Minor from a “hold” rating to a “strong sell” rating in a report on Tuesday, September 2nd. Finally, JPMorgan Chase & Co. decreased their price objective on Owens & Minor from $7.00 to $6.00 and set an “underweight” rating for the company in a report on Wednesday, August 27th. One equities research analyst has rated the stock with a Strong Buy rating, three have assigned a Buy rating, one has issued a Hold rating and three have assigned a Sell rating to the company’s stock. According to MarketBeat.com, the company presently has an average rating of “Hold” and an average target price of $7.63.

Insider Activity at Owens & Minor

In other Owens & Minor news, major shareholder Coliseum Capital Management, L bought 492,852 shares of the company’s stock in a transaction dated Thursday, August 14th. The shares were purchased at an average cost of $5.31 per share, for a total transaction of $2,617,044.12. Following the transaction, the insider directly owned 13,100,807 shares of the company’s stock, valued at approximately $69,565,285.17. The trade was a 3.91% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the SEC, which is available through this hyperlink. In the last 90 days, insiders bought 1,537,852 shares of company stock worth $8,099,544. 3.69% of the stock is owned by company insiders.

Owens & Minor Price Performance

NYSE:OMI opened at $4.95 on Wednesday. Owens & Minor, Inc. has a 52 week low of $4.56 and a 52 week high of $16.47. The company has a quick ratio of 0.83, a current ratio of 0.86 and a debt-to-equity ratio of 3.32. The stock has a market capitalization of $382.34 million, a PE ratio of -0.32 and a beta of 1.03. The stock’s 50-day moving average price is $6.31 and its 200-day moving average price is $7.36.

Owens & Minor (NYSE:OMI) last posted its earnings results on Monday, August 11th. The company reported $0.26 EPS for the quarter, missing analysts’ consensus estimates of $0.27 by ($0.01). Owens & Minor had a negative net margin of 13.78% and a positive return on equity of 26.59%. The business had revenue of $681.90 million for the quarter, compared to analyst estimates of $2.73 billion. During the same quarter last year, the business earned $0.36 earnings per share. Owens & Minor’s revenue was up 3.3% on a year-over-year basis. Owens & Minor has set its FY 2025 guidance at 1.020-1.070 EPS. As a group, equities analysts expect that Owens & Minor, Inc. will post 1.51 EPS for the current fiscal year.

Owens & Minor Profile

Owens & Minor, Inc is a healthcare solutions company, which engages in the product manufacturing and delivery, home health supply, and perioperative services to support care through the hospital and into the home. It operates through the Products and Healthcare Services, and Patient Direct segments.